Skip to main content
. 2021 Sep 17;11:719542. doi: 10.3389/fcimb.2021.719542

Figure 1.

Figure 1

BefA protein improves blood glucose and body weight in MLD-STZ induction of T1DM mice. (A) Treatment schedule of BefA protein for MLD-STZ induction of T1DM model. (B, C) Changes in blood sugar and body weight over time in C, M, MB and MM group (n = 12). (D, E) Levels of blood glucose and area under the curve (AUC) during a GTT in C, M, MB and MM group (n = 6). Data are presented as means ± SD. Two-way repeated-measures ANOVA both with Tukey’s test for multiple comparisons (B–D, respectively) and One way repeated-measures ANOVA with Tukey’s test for multiple comparisons (E); *p < 0.05, **p < 0.01.